Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Salloway

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of the Neurological Sciences|November 6, 2002
Effect of APOE genotype on microvascular basement membrane in Alzheimer's diseaseS Salloway, T Gur, T Berzin, et al.
The Journal of Prevention of Alzheimer'S Disease|March 28, 2025
Donanemab: Appropriate use recommendationsG D Rabinovici, D J Selkoe, S E Schindler, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task ForceS Gauthier, J Alam, H Fillit, et al.
AJNR. American Journal of Neuroradiology|April 13, 2013
MR imaging features of amyloid-related imaging abnormalitiesJ Barakos, R Sperling, S Salloway, et al.
Neurology|September 16, 2011
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseS Salloway, R Sperling, R Keren, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Translational Psychiatry|May 15, 2023
Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical responseN C R McLaughlin, J F Magnotti, G P Banks, et al.
Revue Neurologique|September 11, 2013
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trialS M Mills, J Mallmann, A M Santacruz, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of the Neurological Sciences|November 6, 2002
Effect of APOE genotype on microvascular basement membrane in Alzheimer's diseaseS Salloway, T Gur, T Berzin, et al.
The Journal of Prevention of Alzheimer'S Disease|March 28, 2025
Donanemab: Appropriate use recommendationsG D Rabinovici, D J Selkoe, S E Schindler, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task ForceS Gauthier, J Alam, H Fillit, et al.
AJNR. American Journal of Neuroradiology|April 13, 2013
MR imaging features of amyloid-related imaging abnormalitiesJ Barakos, R Sperling, S Salloway, et al.
Neurology|September 16, 2011
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseS Salloway, R Sperling, R Keren, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Translational Psychiatry|May 15, 2023
Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical responseN C R McLaughlin, J F Magnotti, G P Banks, et al.
Revue Neurologique|September 11, 2013
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trialS M Mills, J Mallmann, A M Santacruz, et al.
Pageof 5